Roche chief executive Thomas Schinecker said today that one in five of the pharma division’s pipeline of new molecular entities (NMEs) has been culled in the last few months as part of a shift in ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS). The ...

Banish the hassle of cables with this wireless printer that is 'sleek and simple' to use. Amazon is selling the HP DeskJet 2820e All in One Printer for £39 reduced from £59.99. Over 8,000 shoppers ...

Promising results of Novo Nordisk's experimental obesity drug, amycretin, from a mid-stage trial could give the drugmaker much-needed heft to reclaim lost ground in the weight-loss market, which is ...

Finding the right smartphone doesn’t have to break the bank. In our list of best mobile phones under 8000, we’ve selected the best models based on the Digit Specs Score, which evaluates devices ...

CURRENTLY TRACKING: Wet and mild conditions are expected through today, followed by snow, wind, and colder conditions for Wednesday and Thanksgiving. Becoming windy with some rain showers turning to ...

Objective: Previous randomized controlled trials have shown good efficacy and safety of omadacycline in patients with infectious diseases, but relevant real-world evidence is still insufficient. This ...